DrugBank ID: db00146
Synonymous :(3s,5z,7e)-9,10-secocholesta-5,7,10-triene-3,25-diol | (3β,5z,7e)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol | (5z,7e)-(3s)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol | 25-hydroxycholecalciferol | 25-hydroxyvitamin d3 | calcidiol | calcifédiol | calcifediol | calcifediol anhydrous | calcifediolum
Drug Sentece Context
Table 1. Analysis of context sentence of calcifediol gene in 11 abstracts.
|32535032||Several randomized clinical trials using either oral vitamin D or oral Calcifediol (25OHD) are ongoing. […] Based on a pilot study, oral calcifediol may be the most promising approach.|
|32871238||Calcifediol can rapidly increase serum 25OHD concentration. […] We therefore evaluated the effect of calcifediol treatment, on Intensive Care Unit Admission and Mortality rate among Spanish patients hospitalized for COVID-19. […] Eligible patients were allocated at a 2 calcifediol:1 no calcifediol ratio through electronic randomization on the day of admission to take oral calcifediol (0.532 mg), or not. […] Patients in the calcifediol treatment group continued with oral calcifediol (0.266 mg) on day 3 and 7, and then weekly until discharge or ICU admission. […] Of 50 patients treated with calcifediol, one required admission to the ICU (2%), while of 26 untreated patients, 13 required admission (50 %) p value X2 Fischer test p < 0.001. […] Univariate Risk Estimate Odds Ratio for ICU in patients with Calcifediol treatment versus without Calcifediol treatment: 0.02 (95 %CI 0.002-0.17). […] Multivariate Risk Estimate Odds Ratio for ICU in patients with Calcifediol treatment vs Without Calcifediol treatment ICU (adjusting by Hypertension and T2DM): 0.03 (95 %CI: 0.003-0.25). […] Of the patients treated with calcifediol, none died, and all were discharged, without complications. […] The 13 patients not treated with calcifediol, who were not admitted to the ICU, were discharged. […] Our pilot study demonstrated that administration of a high dose of Calcifediol or 25-hydroxyvitamin D, a main metabolite of vitamin D endocrine system, significantly reduced the need for ICU treatment of patients requiring hospitalization due to proven COVID-19. […] Calcifediol seems to be able to reduce severity of the disease, but larger trials with groups properly matched will be required to show a definitive answer.|
|33489300||Randomized placebo-controlled trials of vitamin D in the community are unlikely to complete until spring 2021-although we note the positive results from Spain of a randomized trial of 25-hydroxyvitamin D3 (25(OH)D3 or calcifediol) in hospitalized patients. […] People admitted to the hospital with COVID-19 should have their vitamin D status checked and/or supplemented and consideration should be given to testing high-dose calcifediol in the RECOVERY trial.|